WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2012116142) COMBINED CELL BASED GP96-IG-SIV/HIV, RECOMBINANT GP120 PROTEIN VACCINATION FOR PROTECTION FROM SIV/HIV
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2012/116142    International Application No.:    PCT/US2012/026256
Publication Date: 30.08.2012 International Filing Date: 23.02.2012
IPC:
A61K 39/00 (2006.01)
Applicants: UNIVERSITY OF MIAMI [US/US]; Office of Technology Transfer 1400 NW 10th Avenue, 12th Floor Miami, FL 33136 (US) (For All Designated States Except US).
PODACK, Eckhard, R. [DE/US]; (US) (For US Only).
STRBO, Natasa [HR/US]; (US) (For US Only).
FRANCHINI, Genoveffa [US/US]; (US) (For US Only).
VACCARI, Monica [IT/US]; (US) (For US Only)
Inventors: PODACK, Eckhard, R.; (US).
STRBO, Natasa; (US).
FRANCHINI, Genoveffa; (US).
VACCARI, Monica; (US)
Agent: SPRUILL, W. Murray; Alston & Bird, LLP Bank of America Plaza 101 South Tryon Street, Suite 4000 Charlotte, NC 28280-4000 (US)
Priority Data:
61/445,884 23.02.2011 US
Title (EN) COMBINED CELL BASED GP96-IG-SIV/HIV, RECOMBINANT GP120 PROTEIN VACCINATION FOR PROTECTION FROM SIV/HIV
(FR) GP96-IG-VIS/VIH COMBINÉE D'ORIGINE CELLULAIRE, VACCINATION PAR PROTÉINE GP120 RECOMBINANTE POUR PROTECTION CONTRE LE VIS/VIH
Abstract: front page image
(EN)Compositions are provided comprising heat shock protein, immunoglobulins and retroviral antigens to induce systemic and mucosal immunity to infection from retroviruses such as Human Immunodeficiency Virus (HIV). Methods of treatment provided comprise administration of the compositions, which boost the immune systems response to the retroviral antigens or immunogens.
(FR)L'invention concerne des compositions qui comportent une protéine de choc thermique, des immunoglobulines et des antigènes rétroviraux et qui induisent une immunité systémique et muqueuse contre une infection par des rétrovirus, tels que le virus de l'immunodéficience humaine (VIH). Des méthodes de traitement comprennent l'administration des compositions qui stimulent la réponse des systèmes immunitaires aux antigènes ou aux immunogènes rétroviraux.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)